Quick Asked: Taysha Gene Therapies Contact Us?

Are you searching for Taysha Gene Therapies Contact Us? By using our below available official links ( which are always up to date), you can find contact information without any difficulty. It may list Phone number, Mobile phone, Email Address & Customer service information.
Last update: 27 Apr, 2024 124 Views

Why taysha gene therapies? At Taysha Gene Therapies, we believe the patient always comes first. This is why we are singularly focused on discovering, developing and commercializing gene therapies for the treatment of monogenic diseases of the central nervous system (CNS), both in rare and large patient populations.

Why is taysha investing in rtp? But the RTP investment is aimed at large-scale manufacturing of Taysha’s product line as it evolves. “North Carolina has a thriving life sciences ecosystem with significant expertise in gene therapy manufacturing, and we are delighted to establish our manufacturing center in Durham,” said RA Session II, president, founder and CEO of Taysha.

Where is taysha located? We are rooted in the heart of Dallas, not far from the iconic Spindletop oil field. Through the generations, these hardworking explorers ultimately went on to fund the very research being conducted at UT Southwestern today. At Taysha, we embrace the same diligent, trailblazing mindset our Texan ancestors were known for.

Who are the partners in the taysha recruitment project? Besides NCBiotech, partners in the Taysha recruitment project included the North Carolina Department of Commerce and the Economic Development Partnership of N.C., the North Carolina General Assembly, the North Carolina Community College System, Duke Energy, Durham County, and the Greater Durham Chamber of Commerce.

Listing Results Taysha Gene Therapies Contact Us? Question Answers

Taysha Gene Therapies Biotech Careers

Taysha Gene Therapies. Website: Taysha Gene Therapies. Business Area (s): Gene Therapy. Neurobiology. Description: At Taysha Gene Therapies, we’re on a mission to eradicate monogenic CNS disease for rare and large market indications.

Zacks: Brokerages Expect Taysha Gene Therapies, Inc

8 hours ago · Wall Street analysts predict that Taysha Gene Therapies, Inc. (NASDAQ:TSHA) will post earnings per share (EPS) of ($1.26) for the current quarter, according to Zacks. Zero analysts have issued estimates for Taysha Gene Therapies' earnings. The lowest EPS estimate is ($1.63) and the highest is ($0.96

Taysha Gene Therapies Collaborates with AllStripes on

Rare Daily Staff. Rare disease gene therapy developer Taysha Gene Therapies and AllStripes, formerly known as RDMD, have entered into a multi-year collaboration in which Taysha will leverage AllStripes’ data platform to inform its understanding of SURF1-associated Leigh syndrome natural history and burden of disease, as well as patients’ diagnostic journeys.

Taysha Gene Therapies Employees, Board Members, Advisors

Taysha Gene Therapies has 2 current employee profiles, including VP, Program & Alliance Management Niren Shah. Taysha Gene Therapies has 5 board members and advisors, including Sean Nolan . Contacts

Taysha Gene Therapies Announces Pricing of Initial Public

DALLAS--(BUSINESS WIRE)--Taysha Gene Therapies, Inc. (“Taysha”), a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of

Did the information help you? If so, please share!
If you think the information on this page has been helpful to you, would you be willing to share it? Your sharing is the driving force for our continuous work.
  1. Home ›
  2. T ›
  3. Taysha Gene Therapies Contact Us?